These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 3953602)
1. Legal implications of home health care by nonprofit hospitals. Greenberg RB Am J Hosp Pharm; 1986 Feb; 43(2):386-91. PubMed ID: 3953602 [TBL] [Abstract][Full Text] [Related]
2. Robinson-Patman update: De Modena v. Kaiser Foundation Health Plan. Greenberg RB Am J Hosp Pharm; 1985 Jul; 42(7):1572-4. PubMed ID: 4025357 [TBL] [Abstract][Full Text] [Related]
3. Controversial issues in home health care: a roundtable discussion. McAllister JC; Black BL; Griffin RE; Smith JE Am J Hosp Pharm; 1986 Apr; 43(4):933-46. PubMed ID: 3706341 [TBL] [Abstract][Full Text] [Related]
4. Portland Retail Druggists Association vs Abbott Laboratories et al, part 2. Greenberg RB; Mandl FL Am J Hosp Pharm; 1976 Jul; 33(7):648-51. PubMed ID: 941919 [TBL] [Abstract][Full Text] [Related]
5. Ethical, economic, and professional issues in home health care. Smith WE Am J Hosp Pharm; 1986 Mar; 43(3):695-8. PubMed ID: 3706325 [TBL] [Abstract][Full Text] [Related]
6. Differential pricing of pharmaceuticals and retail competition under the Robinson-Patman Act. Abood RR Am J Law Med; 1985; 11(3):293-317. PubMed ID: 3842232 [TBL] [Abstract][Full Text] [Related]
7. U.S. Supreme Court decision in Jefferson County Pharmaceutical Association v. Abbott Laboratories et al. Podell LB Am J Hosp Pharm; 1983 Sep; 40(9):1537-8. PubMed ID: 6624759 [TBL] [Abstract][Full Text] [Related]
8. Current trends in home health care. Zilz DA Am J Hosp Pharm; 1985 Nov; 42(11):2520-5. PubMed ID: 4073073 [TBL] [Abstract][Full Text] [Related]
9. Antitrust treatment of nonprofit and for-profit hospital mergers. Blair RD; Fesmire JM Adv Health Econ Health Serv Res; 1987; 7():221-44. PubMed ID: 10291981 [No Abstract] [Full Text] [Related]
10. Should not-for-profit organizations be exempt from antitrust laws? Bryant LE Healthc Financ Manage; 1988 Jun; 42(6):70-2, 76-80, 84-5. PubMed ID: 10287603 [TBL] [Abstract][Full Text] [Related]
11. The Copperweld case: antitrust considerations in hospital/home health agency relations. Tillman E Caring; 1984 Oct; 3(10):35. PubMed ID: 10268226 [No Abstract] [Full Text] [Related]
12. Commodity resales by nonprofit entities: antitrust implications for home health agencies. Miles JJ Caring; 1987 May; 6(5):64-8. PubMed ID: 10282958 [No Abstract] [Full Text] [Related]
13. Tax aspects of outpatient drug transactions in nonprofit hospitals. McDaniel PA; Fink JL Am J Hosp Pharm; 1985 Feb; 42(2):352-6. PubMed ID: 3976684 [TBL] [Abstract][Full Text] [Related]
14. A legal drama in 2 acts: why hospital execs should know the law in antitrust defense. Burda D Mod Healthc; 1990 Feb; 20(5):40, 42. PubMed ID: 10103588 [No Abstract] [Full Text] [Related]
15. Portland Retail Druggists Association vs Abbott Laboratories et al, part 1. Greenberg RB Am J Hosp Pharm; 1976 Jun; 33(6):572-3. PubMed ID: 1274976 [TBL] [Abstract][Full Text] [Related]
17. Evaluating alternatives for providing home health-care services. McAllister JC Am J Hosp Pharm; 1985 Nov; 42(11):2533-9. PubMed ID: 4073074 [TBL] [Abstract][Full Text] [Related]
18. How can PPOs control prices without violating antitrust laws? Fried JM Hosp Prog; 1984 Mar; 65(3):34-7. PubMed ID: 10265221 [TBL] [Abstract][Full Text] [Related]